Patents by Inventor Peter A. Altman

Peter A. Altman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10874831
    Abstract: A steerable guide sheath system adapted for delivery into a patient's vasculature. The pull wire which is used to tension the deflectable portion of the sheath is wrapped or twisted around the axis of the sheath.
    Type: Grant
    Filed: October 6, 2015
    Date of Patent: December 29, 2020
    Assignee: BIOCARDIA, INC.
    Inventors: Daniel C. Rosenman, Daniel Kayser, Peter A. Altman
  • Patent number: 10632281
    Abstract: A system and method for delivering a drug to a target site within a patient's body. The system and method include a steerable guide catheter and a drug delivery catheter. The steerable guide catheter has a first extension tube and a second extension tube that are joined together and form a shoulder. The delivery catheter has a distal docking segment and a proximal docking segment. The guide catheter is inserted into the patient's body, then the delivery catheter is inserted into the guide catheter. The distal docking segment engages the first extension tube, the proximal docking segment engages the second extension tube, and the shoulder limits the distance the delivery catheter can be inserted into the guide catheter. Also, once the delivery catheter is inserted it can be rotated to attach the helical tip to the target site. The guide catheter also includes a steering mechanism as well as a friction mechanism which controls the tension on the steering mechanism.
    Type: Grant
    Filed: April 21, 2014
    Date of Patent: April 28, 2020
    Assignee: BioCardia, Inc.
    Inventors: Daniel C. Rosenman, Peter A. Altman, Brian K. Hakim, Daniel J. Kayser, Robert E. Maston, Douglas McEtchin
  • Publication number: 20170266107
    Abstract: A method of treating chronic post-myocardial infarction including helical needle transendocardial delivery of autologous bone marrow (ABM) mononuclear cells around regions of hypo or akinesia in chronic post-myocardial infarction (MI) patients. The treatment is safe and improves ejection fraction (EF).
    Type: Application
    Filed: November 2, 2016
    Publication date: September 21, 2017
    Inventors: Luis M. de la Fuente, Simon H. Stertzer, Julio Argentieri, Eduardo Penaloza, Peter A. Altman
  • Patent number: 9517199
    Abstract: A method of treating chronic post-myocardial infarction including helical needle transendocardial delivery of autologous bone marrow (ABM) mononuclear cells around regions of hypo or akinesia in chronic post-myocardial infarction (MI) patients. The treatment is safe and improves ejection fraction (EF).
    Type: Grant
    Filed: February 24, 2015
    Date of Patent: December 13, 2016
    Assignee: BioCardia, Inc.
    Inventors: Luis M. de la Fuente, Simon H. Stertzer, Julio Argentieri, Eduardo Penaloza, Peter A. Altman
  • Patent number: 9504642
    Abstract: A method of treating chronic post-myocardial infarction including helical needle transendocardial delivery of autologous bone marrow (ABM) mononuclear cells around regions of hypo or akinesia in chronic post-myocardial infarction (MI) patients. The treatment is safe and improves ejection fraction (EF).
    Type: Grant
    Filed: July 30, 2013
    Date of Patent: November 29, 2016
    Assignee: BioCardia, Inc.
    Inventors: Luis M. de la Fuente, Simon H. Stertzer, Julio Argentieri, Eduardo Penaloza, Peter A. Altman
  • Patent number: 9301975
    Abstract: A method for expanding mesenchymal cells derived from autologous bone marrow in autologous culture medium which can be used in a clinical setting, and a business method for performing such expansions in the future as a service for patients. A method for expanding mesenchymal cells derived from autologous bone marrow in autologous culture medium including a diagnostic kit for the autologous cell therapy to determine whether a patient will respond to the autologous cell therapy for treatment of a disease, in which said kit comprising a system for detecting gene and protein expression comprising at least two isolated DNA molecules wherein each isolated DNA molecule detects expression of a gene that is differentially expressed in the tissue of the patient that is intended to be the source of the autologous cell therapy.
    Type: Grant
    Filed: May 1, 2009
    Date of Patent: April 5, 2016
    Assignee: Biocardia, Inc.
    Inventors: Didier Rouy, Peter A. Altman, Benjamin Koziner
  • Publication number: 20160022961
    Abstract: A steerable guide sheath system adapted for delivery into a patient's vasculature. The pull wire which is used to tension the deflectable portion of the sheath is wrapped or twisted around the axis of the sheath.
    Type: Application
    Filed: October 6, 2015
    Publication date: January 28, 2016
    Applicant: BIOCARDIA, INC.
    Inventors: Daniel C. Rosenman, Daniel Kayser, Peter A. Altman
  • Publication number: 20150314106
    Abstract: Methods for easy, atraumatic access to areas of the vasculature that are otherwise difficult to access, using steerable guide catheters constructed with components that are selected to provide optimal navigability, torque transfer, and push ability for a variety of typical percutaneous access routes. The catheter wall thickness in the deflecting segment of the guide catheter is about 1 French (? mm) or less, and includes a slotted deflection tube, and this construction allows a very tight turning radius which in turn enables guide catheter access to regions of the vasculature that are otherwise inaccessible.
    Type: Application
    Filed: July 13, 2015
    Publication date: November 5, 2015
    Applicant: Biocardia, Inc.
    Inventors: Daniel C. Rosenman, Daniel Kayser, Michael Keleher, Nick Fravala, Richard Cook, Mark Tale, Frank Arko, Simon Stertzer, Peter A. Altman
  • Patent number: 9078994
    Abstract: Methods for easy, atraumatic access to areas of the vasculature that are otherwise difficult to access, using steerable guide catheters constructed with components that are selected to provide optimal navigability, torque transfer, and push ability for a variety of typical percutaneous access routes. The catheter wall thickness in the deflecting segment of the guide catheter is about 1 French (? mm) or less, and includes a slotted deflection tube, and this construction allows a very tight turning radius which in turn enables guide catheter access to regions of the vasculature that are otherwise inaccessible.
    Type: Grant
    Filed: August 13, 2013
    Date of Patent: July 14, 2015
    Assignee: BioCardia, Inc.
    Inventors: Daniel C. Rosenman, Daniel Kayser, Michael Keleher, Nick Fravala, Richard Cook, Mark Tale, Frank Arko, Simon Stertzer, Peter A. Altman
  • Publication number: 20150164786
    Abstract: A method of treating chronic post-myocardial infarction including helical needle transendocardial delivery of autologous bone marrow (ABM) mononuclear cells around regions of hypo or akinesia in chronic post-myocardial infarction (MI) patients. The treatment is safe and improves ejection fraction (EF).
    Type: Application
    Filed: February 24, 2015
    Publication date: June 18, 2015
    Applicant: BioCardia, Inc.
    Inventors: Luis M. de la Fuente, Simon H. Stertzer, Julio Argentieri, Eduardo Penaloza, Peter A. Altman
  • Patent number: 9022977
    Abstract: Methods for easy, atraumatic access to areas of the vasculature that are otherwise difficult to access, using steerable guide catheters constructed with components that are selected to provide optimal navigability, torque transfer, and push ability for a variety of typical percutaneous access routes. The catheter wall thickness in the deflecting segment of the guide catheter is about 1 French (? mm) or less, and includes a slotted deflection tube, and this construction allows a very tight turning radius which in turn enables guide catheter access to regions of the vasculature that are otherwise inaccessible.
    Type: Grant
    Filed: June 11, 2013
    Date of Patent: May 5, 2015
    Assignee: BioCardia, Inc.
    Inventors: Daniel C. Rosenman, Daniel Kayser, Michael Keleher, Nick Fravala, Richard Cook, Mark Tale, Frank Arko, Simon Stertzer, Peter A. Altman
  • Patent number: 9017284
    Abstract: Methods for easy, atraumatic access to areas of the vasculature that are otherwise difficult to access, using steerable guide catheters constructed with components that are selected to provide optimal navigability, torque transfer, and push ability for a variety of typical percutaneous access routes. The catheter wall thickness in the deflecting segment of the guide catheter is about 1 French (? mm) or less, and includes a slotted deflection tube, and this construction allows a very tight turning radius which in turn enables guide catheter access to regions of the vasculature that are otherwise inaccessible.
    Type: Grant
    Filed: August 13, 2013
    Date of Patent: April 28, 2015
    Assignee: BioCardia, Inc.
    Inventors: Daniel C. Rosenman, Daniel Kayser, Michael Keleher, Nick Fravala, Richard Cook, Mark Tale, Frank Arko, Simon Stertzer, Peter A. Altman
  • Patent number: 9011373
    Abstract: Methods for easy, atraumatic access to areas of the vasculature that are otherwise difficult to access, using steerable guide catheters constructed with components that are selected to provide optimal navigability, torque transfer, and push ability for a variety of typical percutaneous access routes. The catheter wall thickness in the deflecting segment of the guide catheter is about 1 French (? mm) or less, and includes a slotted deflection tube, and this construction allows a very tight turning radius which in turn enables guide catheter access to regions of the vasculature that are otherwise inaccessible.
    Type: Grant
    Filed: August 13, 2013
    Date of Patent: April 21, 2015
    Assignee: BioCardia, Inc.
    Inventors: Daniel C. Rosenman, Daniel Kayser, Michael Keleher, Nick Fravala, Richard Cook, Mark Tale, Frank Arko, Simon Stertzer, Peter A. Altman
  • Publication number: 20150041532
    Abstract: A system and method for tracking longitudinal data for the maintenance and management of health of an individual. The method entails marking numerous groceries, drugs, beverages, etc., with labels that may be read by a scanner or reader embedded in a PDA or cell phone or similar small electronic device, and providing users with a suitable scanner or reader. Users scan the labels of the products they consume during the course of a day, and the system keeps track of calories, fat content, carbohydrate content, etc. of the food consumed, drug content of the drugs consumed, etc. The system can also be operated to track exercise levels and energy expenditure during the day. The system is operable to provide a comparative display of various databased information, such as calorie intake versus calorie expenditure during exercise.
    Type: Application
    Filed: October 22, 2014
    Publication date: February 12, 2015
    Inventor: Peter A. Altman
  • Patent number: 8939960
    Abstract: Methods for easy, atraumatic access to areas of the vasculature that are otherwise difficult to access, using steerable guide catheters constructed with components that are selected to provide optimal navigability, torque transfer, and push ability for a variety of typical percutaneous access routes. The catheter wall thickness in the deflecting segment of the guide catheter is about 1 French (? mm) or less, and includes a slotted deflection tube, and this construction allows a very tight turning radius which in turn enables guide catheter access to regions of the vasculature that are otherwise inaccessible.
    Type: Grant
    Filed: July 22, 2008
    Date of Patent: January 27, 2015
    Assignee: BioCardia, Inc.
    Inventors: Daniel Rosenman, Daniel Kayser, Michael Keleher, Nick Fravala, Richard Cook, Mark Tale, Frank Arko, Simon Stertzer, Peter A. Altman
  • Publication number: 20140228748
    Abstract: A system and method for delivering a drug to a target site within a patient's body. The system and method include a steerable guide catheter and a drug delivery catheter. The steerable guide catheter has a first extension tube and a second extension tube that are joined together and form a shoulder. The delivery catheter has a distal docking segment and a proximal docking segment. The guide catheter is inserted into the patient's body, then the delivery catheter is inserted into the guide catheter. The distal docking segment engages the first extension tube, the proximal docking segment engages the second extension tube, and the shoulder limits the distance the delivery catheter can be inserted into the guide catheter. Also, once the delivery catheter is inserted it can be rotated to attach the helical tip to the target site. The guide catheter also includes a steering mechanism as well as a friction mechanism which controls the tension on the steering mechanism.
    Type: Application
    Filed: April 21, 2014
    Publication date: August 14, 2014
    Applicant: BioCardia, Inc.
    Inventors: Daniel C. Rosenman, Peter A. Altman, Brian K. Hakim, Daniel J. Kayser, Robert E. Maston, Douglas McEtchin
  • Publication number: 20140012189
    Abstract: Catheter systems and methods for implanting helical or dart-like implants into the myocardium or other body tissue. The catheter system includes a helix for fixing the distal end of the catheter to the myocardium, an implant held by the helix, mechanisms for driving the fixation helix into the myocardium, and mechanisms for driving the implant into the myocardium, removing the fixation helix and leaving the implant behind. The implant may be coated, filled, or made of a drug or drug eluting compound, or drug delivery matrix of any composition.
    Type: Application
    Filed: September 10, 2013
    Publication date: January 9, 2014
    Applicant: BioCardia, Inc.
    Inventors: Daniel C. Rosenman, Peter A. Altman, Mark A. Lovich, Michael A. Schwartz, Aaron J. Miller
  • Publication number: 20130331932
    Abstract: Methods for easy, atraumatic access to areas of the vasculature that are otherwise difficult to access, using steerable guide catheters constructed with components that are selected to provide optimal navigability, torque transfer, and push ability for a variety of typical percutaneous access routes. The catheter wall thickness in the deflecting segment of the guide catheter is about 1 French (? mm) or less, and includes a slotted deflection tube, and this construction allows a very tight turning radius which in turn enables guide catheter access to regions of the vasculature that are otherwise inaccessible.
    Type: Application
    Filed: August 13, 2013
    Publication date: December 12, 2013
    Applicant: BioCardia, Inc.
    Inventors: Daniel C. Rosenman, Daniel Kayser, Michael Keleher, Nick Fravala, Richard Cook, Mark Tale, Frank Arko, Simon Stertzer, Peter A. Altman
  • Publication number: 20130331819
    Abstract: Methods for easy, atraumatic access to areas of the vasculature that are otherwise difficult to access, using steerable guide catheters constructed with components that are selected to provide optimal navigability, torque transfer, and push ability for a variety of typical percutaneous access routes. The catheter wall thickness in the deflecting segment of the guide catheter is about 1 French (? mm) or less, and includes a slotted deflection tube, and this construction allows a very tight turning radius which in turn enables guide catheter access to regions of the vasculature that are otherwise inaccessible.
    Type: Application
    Filed: August 13, 2013
    Publication date: December 12, 2013
    Applicant: BioCardia, Inc.
    Inventors: Daniel C. Rosenman, Daniel Kayser, Michael Keleher, Nick Fravala, Richard Cook, Mark Tale, Frank Arko, Simon Stertzer, Peter A. Altman
  • Publication number: 20130331881
    Abstract: Methods for easy, atraumatic access to areas of the vasculature that are otherwise difficult to access, using steerable guide catheters constructed with components that are selected to provide optimal navigability, torque transfer, and push ability for a variety of typical percutaneous access routes. The catheter wall thickness in the deflecting segment of the guide catheter is about 1 French (1/3 mm) or less, and includes a slotted deflection tube, and this construction allows a very tight turning radius which in turn enables guide catheter access to regions of the vasculature that are otherwise inaccessible.
    Type: Application
    Filed: August 13, 2013
    Publication date: December 12, 2013
    Applicant: BioCardia, Inc.
    Inventors: Daniel C. Rosenman, Daniel Kayser, Michael Keleher, Nick Fravala, Richard Cook, Mark Tale, Frank Arko, Simon Stertzer, Peter A. Altman